158 related articles for article (PubMed ID: 108701)
1. Behavioral evidence for supersensitivity after chronic bromocriptine administration.
Smith RC; Strong JR; Hicks PB; Samorajski T
Psychopharmacology (Berl); 1979 Feb; 60(3):241-6. PubMed ID: 108701
[TBL] [Abstract][Full Text] [Related]
2. The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
Globus M; Bannet J; Lerer B; Belmaker RH
Psychopharmacology (Berl); 1982; 78(1):81-4. PubMed ID: 6815701
[TBL] [Abstract][Full Text] [Related]
3. Hypothesis: bromocriptine lacks intrinsic dopamine receptor stimulating properties.
Jackson DM; Jenkins OF
J Neural Transm; 1985; 62(3-4):219-30. PubMed ID: 3897455
[TBL] [Abstract][Full Text] [Related]
4. The effects on central dopamine function of chronic L-dopa (methyl ester hydrochloride) treatment of mice.
Tabar J; Hashizume M; Cook CJ; Beart PM; Jackson DM
Pharmacol Biochem Behav; 1989 May; 33(1):139-46. PubMed ID: 2789405
[TBL] [Abstract][Full Text] [Related]
5. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
Johnson AM; Loew DM; Vigouret JM
Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
[TBL] [Abstract][Full Text] [Related]
6. Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice.
Jenkins OF; Jackson DM
Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):7-11. PubMed ID: 3877878
[TBL] [Abstract][Full Text] [Related]
7. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and biochemical evidence for a different effect of repeated administration of L-dopa and bromocriptine on denervated versus non-denervated striatal dopamine receptors.
Rouillard C; Bédard PJ; Falardeau P; Dipaolo T
Neuropharmacology; 1987 Nov; 26(11):1601-6. PubMed ID: 3431663
[TBL] [Abstract][Full Text] [Related]
9. Bromocriptine induces climbing behaviour: possible D-1 or D-2 dopamine receptor involvement.
Zarrindast MR; Shahed-Dirin K
Psychopharmacology (Berl); 1990; 100(2):275-80. PubMed ID: 2305016
[TBL] [Abstract][Full Text] [Related]
10. Combined administration of direct dopamine receptor agonists and L-dopa does not interfere with utilization of exogenous L-dopa in rat corpus striatum.
Globus M; Melamed E
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):211-5. PubMed ID: 6310691
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of apomorphine from bromocriptine, piribidel and TRH by chronic administration in rats.
Porreca F; Cowan A; Tallarida RJ
Psychopharmacology (Berl); 1982; 76(1):70-4. PubMed ID: 6805012
[No Abstract] [Full Text] [Related]
12. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD
Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859
[TBL] [Abstract][Full Text] [Related]
13. Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats.
Kenny AM; Schneider MB; Baden DR; Pfeiffer RF; Murrin LC
Neurology; 1986 Mar; 36(3):400-4. PubMed ID: 3081831
[TBL] [Abstract][Full Text] [Related]
14. Chronic treatment with bromocriptine induces behavioral supersensitivity in rats.
Hassan MN; Higgins D; Traub M; Fahn S
Life Sci; 1986 Aug; 39(6):513-8. PubMed ID: 3090394
[TBL] [Abstract][Full Text] [Related]
15. Receptor changes during chronic dopaminergic stimulation.
Jenner P; Boyce S; Marsden CD
J Neural Transm Suppl; 1988; 27():161-75. PubMed ID: 2900291
[TBL] [Abstract][Full Text] [Related]
16. Bromocriptine-induced rotation: characterization using a striatal efferent lesion in the mouse.
Mandel RJ; Randall PK
Brain Res Bull; 1990 Feb; 24(2):175-80. PubMed ID: 2108786
[TBL] [Abstract][Full Text] [Related]
17. Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
Davis A; Jenner P; Marsden CD
Psychopharmacology (Berl); 1990; 100(1):19-26. PubMed ID: 1967499
[TBL] [Abstract][Full Text] [Related]
18. L-dopa causes an acute, partial and reversible reversal of denervation-induced supersensitivity of striatal dopaminergic receptors.
Ferre S; Casas M; Cobos A; Garcia C; Jane F; Grau JM
Psychopharmacology (Berl); 1987; 91(2):254-6. PubMed ID: 3107042
[TBL] [Abstract][Full Text] [Related]
19. Aging and the regulation of striatal dopaminergic mechanisms in mice.
Randall PK; Severson JA; Finch CE
J Pharmacol Exp Ther; 1981 Dec; 219(3):695-700. PubMed ID: 7197719
[TBL] [Abstract][Full Text] [Related]
20. Behavioral effects of dopamine agonists across the estrous cycle in rats.
Steiner M; Katz RJ; Carroll BJ
Psychopharmacology (Berl); 1980; 71(2):147-51. PubMed ID: 6777814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
